Resolian UK
David Butler is an accomplished professional with extensive experience in quality management and regulatory governance. Currently serving as VP of Corporate Quality at Resolian and Director of Regulatory Governance at Drug Development Solutions, David has held leadership roles since October 2011 as Director and Chairman at the Research Quality Association. From December 2012 to July 2022, David was the Director of Quality, Safety, Health & Environment at LGC, where David oversaw the integration of Quotient Bioresearch Ltd's bioanalytical services. Past roles include Director of Quality at Quotient Bioresearch Ltd and Operations Manager at Surface Measurement Systems. David's academic background includes a PhD in Physical Chemistry from the University of Southampton and a Master’s degree in Quality Management from Cranfield University.
This person is not in the org chart
This person is not in any teams
Resolian UK
1 followers
Collaborating on all therapeutic modalities, Resolian fuses expertise from Alliance Pharma and Drug Development Solutions to provide world-class scientific solutions. We are an ever-expanding global team of experts, resolute in our goal to offer an accessible, enhanced customer experience through a personalized approach and proactive management. With Resolian Bioanalytics, our vast expertise, from next-generation biologics to cell and gene therapy, allows us to find solutions to the most challenging bioanalytical methods and assays. Resolian Analytical Sciences builds on two decades of experience solving the most complex challenges in testing raw materials, formulated products, packaging and medical devices for trace impurities, contamination, degradation and quality control. Learn more about us at resolian.com.